Related Experiment Video
Updated: Dec 27, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
High Levels of Class I Major Histocompatibility Complex mRNA Are Present in Epstein-Barr Virus-Associated Gastric
Farhad Ghasemi1, Steven F Gameiro2, Tanner M Tessier2
1Department of Surgery, Western University, London, ON N6A 3K7, Canada.
Abstract:
Epstein-Barr virus (EBV) is responsible for approximately 9% of stomach adenocarcinomas. EBV-encoded microRNAs have been reported as reducing the function of the class I major histocompatibility complex (MHC-I) antigen presentation apparatus, which could allow infected cells to evade adaptive immune responses. Using data from nearly 400 human gastric carcinomas (GCs), we assessed the impact of EBV on MHC-I heavy and light chain mRNA levels, as well as multiple other components essential for antigen processing and presentation. Unexpectedly, mRNA levels of these genes were as high, or higher, in EBV-associated gastric carcinomas (EBVaGCs) compared to normal control tissues or other GC subtypes. This coordinated upregulation could have been a consequence of the higher intratumoral levels of interferon γ in EBVaGCs, which correlated with signatures of increased infiltration by T and natural killer (NK) cells. These results indicate that EBV-encoded products do not effectively reduce mRNA levels of the MHC-I antigen presentation apparatus in human GCs.
Insights
Epstein-Barr virus (EBV) does not reduce major histocompatibility complex I (MHC-I) in most stomach cancers. Instead, EBV-associated gastric cancers show higher MHC-I mRNA levels, suggesting a different immune response mechanism.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Epstein-Barr virus (EBV) is linked to 9% of stomach adenocarcinomas.
- EBV microRNAs were previously thought to evade immune responses by reducing MHC-I antigen presentation.
- This study investigates EBV's effect on the MHC-I pathway in gastric cancer.
Purpose of the Study:
- To assess the impact of EBV on MHC-I heavy and light chain mRNA levels in human gastric carcinomas.
- To investigate the relationship between EBV, MHC-I expression, and immune cell infiltration in gastric cancer.
Main Methods:
- Analysis of mRNA levels for MHC-I components and antigen processing/presentation factors.
- Utilized data from nearly 400 human gastric carcinomas (GCs).
- Correlated gene expression with intratumoral interferon-gamma levels and immune cell infiltration.
Main Results:
- Contrary to expectations, MHC-I mRNA levels were not reduced in EBV-associated gastric carcinomas (EBVaGCs).
- MHC-I and related gene mRNA levels were as high or higher in EBVaGCs compared to normal tissues and other GC subtypes.
- Upregulation correlated with increased interferon-gamma and T/NK cell infiltration in EBVaGCs.
Conclusions:
- EBV-encoded products do not effectively reduce MHC-I antigen presentation machinery mRNA levels in human gastric cancer.
- EBVaGCs exhibit an upregulation of MHC-I pathway components, potentially driven by interferon-gamma.
- This suggests a complex interplay between EBV and the host immune response in gastric carcinogenesis.
Related Concept Videos
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Abnormal Proliferation
Non-LTR Retrotransposons

